xFOREST Therapeutics aims to create a paradigm shift in drug discovery with its unique technological assets "FOREST", setting RNA structures as drug discovery targets. FOREST are technology platforms that integrate massively parallel biochemical analysis systems of up to 1 million species of RNA structures and in silico analysis pipelines. These comprehensive analyses include various RNA structures, regardless of their source: organ, species, or virus. As a result, the technologies have enabled the search for highly specific RNA-binders, empowering the rapid and efficient discovery of RNA-targeting drugs.